CCR9–/– mice are more susceptible to DSS colitis than WT littermate controls as shown by higher mortality, increased IBD score, and delayed recovery. During recovery, the CCR9–/– colonic mucosa is characterized by the accumulation of activated macrophages and elevated levels of Th1/Th17 inflammatory cytokines. This evidence concerns the gene CCR9 and inflammatory bowel disease.